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AKT, protein kinase B 
CQ, chloroquine 
DN, dominant negative 
ERK, extracellular signal-regulated kinase 
FBS, fetal bovine serum 
JNK, c-Jun N-terminal kinase 
LC3-II, microtubule-associated protein 1 light chain 3 II 
3-MA, 3-methyladenine 
MAPK, mitogen-activated protein kinase  
PARP-1, poly(ADP-ribose) polymerase  
PBS, phosphate buffered saline 
Pc, phthalocyanine  
PDT, photodynamic therapy  
p.i., post irradiation  
PI3K, phosphatidylinositol 3-kinase 
PS, photosensitizer 
ROS, reactive oxygen species 





Melanoma is the most aggressive type of skin cancer, highly resistant to conventional 
therapies. Photodynamic therapy (PDT) is a minimally invasive treatment modality that 
combines the use of a photosensitizer, visible light and molecular oxygen, leading to 
ROS generation in the specific site of irradiation. The cationic zinc(II) phthalocyanine 
Pc13 has shown to be a potent photosensitizer in different melanoma cell lines. In this 
study, we explored the intracellular signaling pathways triggered by Pc13 PDT and the 
role of these cascades in the phototoxic action of Pc13 in human melanoma A375 cells. 
ROS-dependent activation of MAPKs p38, ERK, JNK and PI3K-I/AKT was observed 
after treatment. Inhibition of p38 reduced Pc13 phototoxicity, whereas blockage of ERK 
did not affect this response. Conversely, JNK inhibition potentiated the effect of Pc13 
PDT. Results obtained indicate that p38 is involved in the cleavage of PARP-1, an 
important mediator of apoptosis. On the other hand, Pc13 irradiation induced the 
activation of an autophagic program, as evidenced by enhanced levels of Beclin-1, LC3-
II and GFP-LC3 punctate staining. We also demonstrated that this autophagic response 
is promoted by JNK and negatively regulated by PI3K- /AKT pathway. The blockage of 
autophagy increased Pc13 phototoxicity and enhanced PARP-1 cleavage, revealing a 
protective role of this mechanism, which tends to prevent apoptotic cell death. 
Furthermore, reduced susceptibility to treatment and increased activation of autophagy 
were detected in A375 cells submitted to repeated cycles of Pc13 PDT, indicating that 
autophagy could represent a mechanism of resistance to PDT. The efficacy of Pc13 
PDT and an improved phototoxic action in combination with chloroquine were also 
demonstrated in tumor spheroids. In conclusion, we showed the interplay between 
apoptotic and autophagic signaling pathways triggered by Pc13 PDT-induced oxidative 
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stress. Thus, autophagy modulation represents a promising therapeutic strategy to 
potentiate the efficacy of PDT in melanoma. 
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1. Introduction 
Melanoma is a malignant and highly invasive skin carcinoma originated in melanocytes 
that represents the principal cause of cell death due to skin cancer. A recent study of the 
International Agency for Research on Cancer (IARC) of the World Health Organization 
(WHO) reported 287,723 new cases of melanoma worldwide in 2018 [1]. Although 
immunotherapy and targeted therapies have shown increased overall survival and 
progression-free survival of patients with melanoma, durable responses only occur in 
some patients, and those who initially respond can ultimately develop resistance after 
continued treatment [2]. Since the incidence of melanoma has notably increased in the 
last decade and given its intrinsic resistance to avail ble therapies, new therapeutic 
alternatives need to be explored. 
Photodynamic therapy (PDT) is a minimally invasive th rapeutic procedure that 
combines the use of a non-toxic photosensitizer (PS) and visible light in order to exert a 
selective cytotoxic activity toward malignant cells. Irradiation at a wavelength 
corresponding to an absorbance band of the PS produces its excitation, which in the 
process of deactivation generates reactive oxygen species (ROS) by two main 
mechanisms, known as type I and type II reactions [3,4]. A type I process occurs when 
PS reacts directly with an organic molecule in a cellular microenvironment to form 
radicals and cytotoxic species, such as superoxide anion, hydrogen peroxide and 
hydroxyl radicals. In type II reactions, PS transfer  its energy to molecular oxygen, 
leading to the formation of singlet oxygen (1O2), a highly cytotoxic molecule [5]. 
Accumulation of ROS leads to oxidative stress, a condition in which cellular 
constituents, including proteins, DNA and lipids are oxidized and damaged [6]. Host 
survival depends on the ability of cells to adapt to or resist the stress, and repair or 
remove damaged molecules. Numerous stress response mechanisms are rapidly 
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activated in response to oxidative insults, including non-enzymatic and enzymatic 
antioxidizing agents [7,8]. In addition, ROS activae different intracellular signaling 
pathways and can elicit a wide spectrum of responses, uch as proliferation, growth 
arrest, senescence and cell death [9]. The response dep nds on the cell type, the 
stimulus examined, its dose and duration [10]. Mitogen-activated protein kinases 
(MAPKs) are a large number of serine/threonine kinases that can be activated in 
response to oxidant injury. MAPKs are divided into three multimember subfamilies: the 
extracellular signal-regulated kinases (ERK), the c-Jun N-terminal kinases (JNK), and 
the p38 kinases [11,12]. Phosphoinositide 3-kinase (PI3K) pathway is also regulated by 
ROS [13,14]. PI3K catalyzes the synthesis of the second messenger 
phosphatidylinositol 3,4,5 triphosphate (PIP3) from phosphatidylinositol 4,5 
bisphosphate (PIP2). In the membrane, PIP3 recruits proteins such as the 
phosphoinositide dependent protein kinase (PDK) and protein kinase B (AKT), which 
are activated and mediate further downstream signaling events [15]. It was proposed 
that ROS may activate MAPK and PI3K pathways through the oxidative modification 
of intracellular kinases [9,16].  
The increase of ROS can also trigger autophagy, an essential process that 
consists of selective degradation of cellular components. Under stress conditions 
autophagy has a pro-survival role involved in the turnover of proteins and elimination of 
damaged or aged organelles and cytoplasmic components to maintain cell homeostasis 
[17,18]. However, extensive autophagy or inappropriate activation of autophagy may be 
deleterious and lead to cell death [19–21]. In addition, the induction of an autophagic 
response has been demonstrated after photodynamic treatment, but dual roles of this 
process have been described, since it may induce eith r a survival response or contribute 
to a death pathway [22–24].  
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MAPKs and PI3K/AKT pathways have been associated with both apoptotic and 
autophagic responses [25–28]. Although activation of ERK, JNK and p38 has been 
reported in PDT-treated cells, the roles of these signaling pathways depend on the cell 
line and/or photosensitizer used [22,29–31]. In a previous work we demonstrated that 
the cationic zinc(II) phthalocyanine 2,9(10),16(17),23(24)-tetrakis[(2-
trimethylammonium)ethylsulfanyl]phthalocyaninatozinc(II) tetraiodide (Pc13) (Fig. 1A) 
is a potent photosensitizer in a wide range of melanoma cell lines. The irradiation of 
Pc13 in melanoma cells simultaneously activates apoptotic and necrotic mechanisms, 
and the extent of cell death by necrosis can be modulated by Pc13 concentration and/or 
the light dose employed [32]. The aim of the present work is to explore the intracellular 
signaling pathways induced by Pc13 PDT in melanoma cells and the participation of 
these cascades in the phototoxic mechanism of Pc13. Results obtained demonstrated 
that the photodynamic treatment induced a ROS-dependent activation of MAPKs p38, 
JNK and ERK, and PI3K/AKT. Moreover, pro-survival autophagy was triggered after 
Pc13 PDT and this mechanism was increased in resistant cells submitted to repeated 
cycles of PDT. Inhibition of autophagy potentiated apoptotic cell death, demonstrating 
the interplay between both mechanisms in the photodynamic effect of Pc13 in 
melanoma cells. We also demonstrated the efficacy of Pc13 PDT and a potentiated 
phototoxicity of the combination with the autophagy inhibitor chloroquine in three-
dimensional (3D) cellular aggregates. The study of the signaling pathways triggered by 
a potent second generation photosensitizer and the crosstalk between cell death and pro-
survival mechanisms emphasizes the clinical relevance of combined therapies for 





2. Materials and methods 
 
2.1. Chemicals 
Synthesis and purification of the sulfur-linked cationic 2,9(10),16(17),23(24)-
tetrakis[(2-trimethylammonium)ethylsulfanyl]phthalocyaninatozinc(II) tetraioidide, 
named Pc13, has been previously described [33]. The antioxidant 6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid (trolox) was from Sigma Chemical (St. Louis, 
MO). The p38 inhibitor SB 203580 was obtained from Santa Cruz Biotechnology (CA, 
USA). The JNK1/2 inhibitor SP 600125 was from Cayman Chemical Company (MI, 
USA) and the MEK inhibitor PD 98059 was from Promega (WI, USA). Autophagy 
inhibitors employed were wortmannin (WM) (Calbiochem, Darmstadt, Germany), 3-
methyladenine (3-MA) (Santa Cruz Biotechnology, CA, USA) and chloroquine (CQ) 
(Sigma-Aldrich, MO, USA). Lipofectamine 3000 was provided by Thermo Fisher 
Scientific (MA, USA).  
 
2.2. Antibodies  
Monoclonal antibodies against phospho-p38 (p-p38), ERK1/2, phospho-JNK1/2 (p-
JNK1/2), phospho-c-Jun (p-c-Jun), Bcl-2, LC3-II, Beclin-1, PARP-1, and the polyclonal 
antibody anti-p38 were obtained from Santa Cruz Biotechnology (CA, USA). 
Polyclonal antibodies directed to phospho-ERK1/2 (p-ERK1/2), phospho-AKT (p-
AKT), and JNK1/2, and monoclonal antibodies against AKT and phospho-p90 (p-p90) 
were from Cell Signaling Technology (MA, USA). Monocl nal antibody against α-
tubulin was purchased from Abcam (UK). Secondary antibodies anti-mouse IgG 
(horseradish peroxidase-conjugated goat IgG) or anti-r bbit IgG (horseradish 




Dominant negative of p38 (DN p38), pcDNA3 p38α T180A/Y182F (Addgene plasmid  
#20352), and  dominant negative of JNK1 (DN JNK1), pCDNA3 Flag JNK1-APF 
(Addgene plasmid #13846), were gifts from Dr. Roger Davis (University of 
Massachusetts Medical School, Worcester, MA, USA). The dominant negative mutant 
of the PI3K-I regulatory subunit p85 (DN PI3K-I), pWZL-neo δp85 del478-513 
(Addgene plasmid #10888), was provided by Dr. William Hahn (Harvard Medical 
School, Boston, MA, USA). Dominant negative constructs of ERK1 and ERK2 (DN 
ERK1/2), pCEP4-ERK1-K71R and pCEP4-ERK2-K52R (Addgene plasmids #49329 
and #39224), were gifts from Dr. Melanie Cobb (University of Texas Southwest 
Medical Center, Dallas, TX, USA). pEGFP-mRFP-LC3 plasmid (Addgene plasmid 
#21074) was kindly provided by Professor Tamotsu Yoshimori (Osaka University, 
Japan). 
 
2.4. Cell culture 
Human melanoma A375 cells (ATCC CRL-1619) were grown in DMEM F-12 medium 
with 10% (v/v) FBS (Natocor, Argentina), 2 mM L-glutamine, 50 U/ml penicillin, 50 
µg/ml streptomycin (Sigma-Aldrich, MO, USA) and 4 mM sodium bicarbonate, in a 
humidified atmosphere of 5% CO2 at 37ºC. 
 
2.5. Photodynamic treatment 
A375 cells grown until ~ 70% confluence were incubated with different concentrations 
of Pc13 in culture medium containing 4% FBS. After 16 h of incubation, cells were 
washed and complete fresh culture medium was added. Then, cells were maintained in 
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the dark or irradiated with a 150 W halogen lamp, equipped with a 10 mm water filter to 
attenuate IR radiation and a 630 nm cut-off filter. A 675 ± 15 nm bandpass filter (CVI 
Melles Griot, Albuquerque, USA) was employed to obtain power output at wavelengths 
to which there is maximum Pc13 absorbance. The total p wer output was 0.28 mW cm-
2, measured with a FieldMate laser power meter (Coherent, Wilsonville, USA) and the 
light dose at 675 ± 15 nm was 340 mJ cm-2 corresponding to 20 min of irradiation. In 
parallel, cells incubated in the absence of Pc13 were used as control. 
 When the effect of inhibitors was evaluated, A375 cells were incubated for 16 h 
with a solution of Pc13 corresponding to its IC50 value (3.60 µM). After washing with 
PBS, cells were pre-incubated for 1 h with 5 mM of the antioxidant trolox, 10 µM SB 
203580, 10 µM SP 600125, 20 µM PD 98059, 0.5 µM wortmannin, 5 mM 3-MA or 20 
µM chloroquine and then irradiated. Phototoxicity was evaluated following 24 h of 
incubation by colorimetric determination of hexosaminidase activity with p-nitrophenol 
substrate as previously described [34]. Absorbance values were measured in a Biotrack 
II Microplate Reader (GE Healthcare, Piscataway, NY).  
 
2.6. Transfections 
A375 cells grown at 70-80% confluence in 6 well-plates were transiently transfected 
with DN p38, DN PI3K-I, DN JNK1, DN ERK1/2 or the corresponding empty vectors 
(2.5 µg/well) using Lipofectamine 3000 reagent, according to the manufacturer’s 
protocol. After overnight incubation, cells were employed for Western blot analysis or 
plated at a density of 1.5x104/well in 96-well microplates and then incubated with IC50 
Pc13 in culture medium containing 4% FBS for 24 h. After washing with PBS, cells 
were irradiated with a light dose of 340 mJ cm-2 and then incubated 24 h before cell 
growth determination by hexosaminidase method. 
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2.7. Western blot assays  
A375 cells (2 × 106) were incubated overnight with 3.60 µM (IC50) Pc13, then washed 
with PBS and exposed to a light dose of 340 mJ cm-2. At different times post irradiation 
(p.i.), cells were lysed for 30 min at 4°C in 10 µl of lysis buffer (0.5% Triton X-100, 1 
µg/ml aprotinin, 1 µg/ml trypsin inhibitor, 1 µg/ml leupeptin, 10 mM Na4P2O7, 10 mM 
NaF, 1 mM Na3VO4, 1 mM EDTA, 1 mM PMSF, 150 mM NaCl, 50 mM Tris, pH 7.4). 
Clear supernatants were centrifuged at 17,000×g for 10 min at 4°C and protein 
concentration was determined using Bradford reagent. Aliquots containing 50 µg of 
protein were resuspended in 0.063 M Tris/HCl, pH 6.8, 2% SDS, 10% glycerol, 0.05% 
bromophenol blue, 5% 2-mercaptoethanol, submitted to SDS-PAGE and then 
transferred to PVDF membranes (GE Healthcare, Piscataway, NY) for 1 h at 100 mA 
per membrane (constant current) using the V20-SDB semi-dry blotting system (Scie-
Plas, Cambridge, UK) in 25 mM Tris, 195 mM glycine, 20% methanol, 0.03% SDS, pH 
8.2. To reduce non-specific binding, membranes were incubated for 1 h at room 
temperature in 10 mM Tris–HCl, 130 mM NaCl and 0.05% Tween 20, pH 7.4, (TBS-
T), containing 5% non-fat milk. Membranes were then incubated overnight at 4°C with 
the primary antibody, washed with TBS-T and incubated with the corresponding 
secondary antibody conjugated with HRP for 1 h at room temperature. Immunoreactive 
proteins were visualized using the ECL Plus detection system (Pierce, Thermo 
Scientific, Rockford, USA) according to the manufacturer´s instructions. For 
quantification of band intensity, membranes were scanned using a densitometer 
(ImageQuant LAS 500, GE Healthcare Life Sciences). Equal protein loading was 
confirmed using a mouse anti-α-tubulin antibody or antibodies against the 
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corresponding non-phosphorylated proteins. Band intensi ies were quantified using Gel-
Pro Analyzer 4.1 software (Media Cybernetics). 
 
2.8. Generation of Pc13 PDT resistant cells 
A375 cells cultured in 25 cm2 flasks and incubated with Pc13 3.60 µM for 24 h, were 
exposed to a light dose of 680 mJ cm-2 (40 min of irradiation). When surviving cells 
proliferated, they were submitted to a new PDT treatm nt [35]. Cell populations that 
received a total of 5 or 10 cycles of Pc13 PDT were obtained and named A3755 PDT and 
A37510 PDT, respectively. Resistant cells were maintained in frozen stocks. Susceptibility 
to Pc13 PDT was evaluated by hexosaminidase method. These cells were also employed 
for Western blot analysis. 
 
2.9. GFP-LC3 overexpression and autophagy detection 
A375 cells grown on coverslips at a density of 6x104 cells/well in 24-well plates were 
transfected with pEGFP-mRFP-LC3 plasmid (0.5 µg/well) using Lipofectamine 3000, 
according to manufacturer’s recommendations. Then, c lls were incubated with IC50 
Pc13 in medium containing 4% FBS for 24 h. After washing with PBS, cells were 
irradiated with a light dose of 340 mJ cm-2 and microphotographs of GFP-LC3 
fluorescence were obtained with a Leica DM2000 fluorescence microscope at 470-490 
nm excitation and 515 nm emission wavelengths at 1 h post-irradiation. Detection of 
punctated green staining of GFP-LC3 indicated the formation of autophagosomes. 
Alternatively, transfections were also performed on A375, A3755 PDT and A37510 
PDT without being submitted to light exposure.  
 
2.10. Formation of 3D tumor spheroids and phototoxicity assay 
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A375 spheroids were generated by the liquid overlay technique [36]. Briefly, A375 cells 
were plated at a density of 2×103 cells/well in U shaped 96-well microplates pre-coated 
with sterile 1% agarose. The formation of spheroids was monitored by optical 
microscopy and spheroids' area was measured using Ima e J software. Spheroids 
reached a diameter of 400-500 µm at 3 days of culture. In order to evaluate Pc13 
phototoxicity, spheroids were incubated with different concentrations of Pc13 in culture 
medium containing 4% FBS. After 24 h, the compound was removed and spheroids 
were exposed to a light dose of 680 mJ cm-2. Spheroid areas were determined at 
different times post irradiation during 10 days. In parallel, non treated spheroids were 
used as control.  
To evaluate spheroid viability, 12 spheroids from each condition were washed 
twice with PBS. Then, spheroids were disaggregated by incubation with trypsin 0.25%, 
EDTA 1mM for 10 min at 37°C. After neutralizing trypsin with complete growth 
medium, cells were resuspended and incubated with MTT (0.5 mg/ml) for 4 h. 
Formazan crystals were obtained by centrifugation at 400 x g and solubilized with 
isopropanol, HCl 0.04 N. Absorbance values at 595 nm were measured in a Biotrack II 
Microplate Reader (GE Healthcare, Piscataway, NY). 
 
2.11. Statistical analysis 
All data was presented and analyzed using GraphPad Prism (Version 6.01, GraphPad 
Software, La Jolla, California, USA, www.graphpad.com). Statistical analyses were 
performed by Student´s t-test (comparing two groups) or One-Way Anova with Dunnett 
post-test (comparing all groups to a control group). Differences in values were 
considered as statistically significant if p-value was less than 0.05 (p<0.05). All 
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3.1. ROS-mediated signaling pathways triggered by Pc13 PDT in A375 cells 
In order to evaluate the susceptibility of human melanoma A375 cells to Pc13 PDT, 
cells were incubated in the presence of different concentrations of Pc13 and then 
irradiated with a light dose of 340 mJ cm-2. As it is expected for all photosensitizers 
employed in PDT, cell viability was not affected in the dark, but a dose-dependent 
phototoxicity of Pc13 was observed after irradiation, being the concentration that caused 
50% of cell death (IC50) of 3.60 ± 0.23 µM (Fig. 1B). When cells were preincubated 
with the antioxidant trolox, the phototoxic effect of Pc13 was blocked, demonstrating 
that ROS are critical mediators of the photodynamic response. 
Since both MAPKs and PI3K/AKT have been identified as signaling pathways 
involved in cellular oxidative stress response, the possible induction of these cascades in 
Pc13 PDT was studied. As shown in Fig. 2A, phosphorylation levels of MAPKs p38, 
ERK1/2 and JNK1/2 increased after phototreatment. While p38 and ERK were activated 
immediately after 20 min of irradiation (time 0 p.i.), the kinetic of JNK activation was 
slower. In addition, a time-dependent phosphorylation of AKT was observed with a 
maximum at 60 min p.i. Based on these findings, the rol  of ROS in the activation of 
these pathways in A375 cells was studied. In this rega d, phosphorylation levels at the 
maximum time of activation for each MAPK and AKT were markedly reduced in the 
presence of 5 mM trolox (Fig. 2B).  
 
3.2. Role of MAPKs and AKT in Pc13 phototoxicity 
Since activation of MAPKs and PI3K-I/AKT pathways were related to both 
proliferation and cell death responses, we next explored the contribution of these 
cascades in Pc13 response. For this purpose, A375 cells were exposed to IC50 of Pc13 
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and irradiated in the presence of specific inhibitors. Cell viability significantly increased 
when cells were preincubated with p38 inhibitor SB 203580, whereas SP 600125, a 
JNK1/2 inhibitor potentiated Pc13 phototoxicity (Fig. 3A). No changes in cell viability 
were observed in the presence of MEK inhibitor PD 98059. Similar studies were 
performed in cells transfected with dominant negative mutants for p38, JNK1 and 
ERK1/2. Transfection efficiency was verified by a reduction in the level of p-p38, p-
cJun or p-p90, respectively (Supplementary Fig. 1). As it was observed with p38 
inhibitor, transfection with DN p38 also reduced Pc13 phototoxicity, suggesting that 
this pathway is involved in cell death. On the other and, DN JNK1 overexpression led 
to increased Pc13 phototoxicity, whereas no changes were observed with DN ERK1/2. 
Finally, transfection with a dominant negative of PI3K-I reduced both AKT 
phosphorylation (Supplementary Fig. 1) and Pc13 phototoxic action (Fig. 3B).  
Since Pc13 phototoxicity was reduced when p38 was inhibited, we then explored 
whether this kinase plays a role in Pc13 PDT-induce apoptosis. In this sense, we have 
previously demonstrated that photodynamic treatment with Pc13 induces a dual 
apoptotic and necrotic response in melanoma cells [32]. The cleavage of PARP-1, a 
marker of apoptosis, was demonstrated after irradiation of Pc13-loaded A375 cells (Fig. 
3C). When cells where preincubated with the inhibitor of p38 SB 203580, a significant 
decrease in the level of the 89 kDa fragment of PAR-1 was observed, suggesting that 
p38 activation is involved in the apoptotic cell death triggered by Pc13 PDT. 
 
3.3. Pc13 photoactivation induces protective autophagy in A375 cells 
Although it has been previously reported that PDT can trigger autophagy, its role in cell 
death is ambiguous. In order to study the involvement of this mechanism in Pc13 
phototoxicity, we investigated the conversion of microtubule-associated protein light 
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chain 3 (LC3-I) to LC3-II. During autophagy, cytosolic LC3-I is conjugated to 
phosphatidylethanolamine and lipidated LC3-II translocates to the autophagosome 
membrane [37]. The amount of LC3-II is closely correlated with autophagosomes 
formation and it is commonly employed as an autophagy indicator. As shown in Fig. 
4A, an increase in LC3-II levels was observed 30 and 60 min after irradiation. 
Moreover, Pc13 PDT dramatically induced green fluorescence shift from a diffuse to a 
punctate pattern in A375 cells transfected with LC3-GFP plasmid (Fig. 4B), indicating 
that cytosolic LC3 was translocated to autophagosome . A marked increase of Beclin-1, 
another regulator of autophagosome formation, was detected after irradiation of Pc13-
treated cells (Fig. 4C). It was reported that BH3 domain of Beclin-1 is bound to, and 
inhibited by Bcl-2 or Bcl-XL [38,39]. Interestingly, we observed a reduction in the 
expression levels of Bcl-2 after treatment, suggesting that Beclin-1 would be free to 
promote autophagosome formation (Fig. 4C).  
 Then, we examined the role of autophagy activation in Pc13 phototoxicity. 
When different inhibitors of autophagy, including chloroquine (CQ) and the PI3K 
inhibitors 3-methyladenine (3-MA) and wortmannin (WM), were employed in 
combination with Pc13 PDT, an enhanced phototoxicity was observed (Fig. 4D). Taken 
together, these results indicate that that autophagy triggered by Pc13 PDT promotes cell 
survival in A375 cells. 
 
3.4. JNK and PI3K-I/AKT regulate Pc13 PDT-induced autophagy 
In order to study the participation of MAPKs in the autophagic response induced by 
irradiation of Pc13 in A375 cells, we used pharmacologic inhibitors of p38 and JNK, 
the kinases that were involved in the phototoxic action of Pc13 (Fig. 3A). As it is shown 
in Fig. 5, while SB 203580 had no effect on the conversion of LC3, the expression of 
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LC3-II was significantly downregulated by SP 600125 in Pc13 PDT treated cells, 
suggesting that JNK activation participates in the induction of autophagy. On the other 
hand, since PI3K inhibitors affect both class I and class III PI3K, we employed a 
dominant negative of PI3K-I to specifically block this pathway. Under this condition, 
the levels of LC3-II were significantly higher than in non transfected cells after Pc13 
PDT (Fig. 5), demonstrating that activation of PI3K-I/AKT pathway inhibits autophagy. 
Thus, JNK and PI3K-I/AKT signaling pathways have opp site roles in the autophagy 
triggered by Pc13 photoactivation. While JNK promotes the conversion of LC3 
involved in autophagosome formation and protects cells from death, PI3K-I/AKT 
blocks this mechanism and increase sensitivity to photodynamic treatment.  
 
3.5. Autophagy is increased in melanoma cells resistant to PDT 
Results obtained demonstrate that autophagy induced by Pc13 PDT has a protective role 
in response to oxidative stress. Therefore, we decided to evaluate whether repeated 
cycles of PDT on melanoma cells could affect the phototoxic outcome through changes 
in the autophagic response. Thus, A375 cells were exposed to 3,60 µM of Pc13 and 
irradiated with a light dose of 680 mJ cm-2. Then, surviving cells were submitted to 
additional four or nine cycles of PDT treatments, leading to A3755 PDT and A37510 PDT 
cells, respectively (Fig. 6A). As it is shown in Figure 6B, IC50 values in A3755 PDT and 
A37510 PDT cells were 6-7 times higher than in parental A375 cells. Furthermore, 
increased levels of LC3-II and a more punctate staining of GFP-LC3 were observed in 
cells that received repeated cycles of PDT (Fig. 6C and 6D). These results demonstrate 
that autophagy is over-stimulated after several photodynamic treatments and this 
produces a reduction in the phototoxic sensitivity.  
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3.6. Inhibition of autophagy increases the PDT apoptotic response and potentiates 
Pc13 phototoxicity in 3D tumor spheroids 
Since Pc13 PDT can trigger both apoptotic and protective autophagic responses, the 
final fate of a cell after irradiation will depend on the balance between cell death and 
prosurvival mechanisms. To evaluate the crosstalk between apoptotic and autophagic 
pathways, cells were incubated with the autophagy inhib tor chloroquine and submitted 
to phototreatment. Western blot analysis revealed that inhibition of autophagy by 20 µM 
chloroquine enhanced Pc13 PDT-induced cleavage of PARP-1 (Fig. 7). Thus, an 
increased induction of apoptosis was obtained when autophagy was blocked, 
demonstrating the interplay between both mechanisms, in which autophagy negatively 
regulates apoptosis in Pc13 phototoxic response. 
The photodynamic effect of Pc13 was subsequently evaluated in 3D culture 
models. After formation, A375 spheroids were exposed to different concentrations of 
Pc13 and irradiated with a light dose of 680 mJ cm-2. Spheroid images obtained by 
optical microscopy were employed to determine areas at different times post irradiation. 
As shown in Fig. 8A, PDT caused a decrease in spheroid growth in a dose dependent 
manner, being 10 µM Pc13 the concentration that produced the maximum effect. The 
reduction of spheroid area correlated with a decrease in cell viability, as determined by 
MTT assay (Fig. supplementary 2).  
When a suboptimal concentration of Pc13 (2.5 µM) was employed, the addition 
of chloroquine potentiated the reduction of spheroid growth, demonstrating that 
autophagy is a protective mechanism that counteracts the phototoxic efficacy of Pc13 in 
3D models, as it was shown in 2D cultures (Fig. 8B).  
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4. Discussion  
Photodynamic therapy is a treatment modality that involves the production of ROS, 
leading to oxidative stress in the irradiated cells. ROS are critical signaling molecules 
involved in a wide variety of cellular processes, such as apoptosis, cell proliferation and 
survival [9]. We have previously demonstrated the ROS-mediated phototoxic effect of 
the zinc phthalocyanine Pc13 in different melanoma cells [32]. In the present work, we 
explored the signaling pathways activated and the intracellular mechanisms triggered by 
Pc13 PDT. We showed that irradiation of human A375 melanoma cells treated with 
Pc13 induced the activation of MAPKs p38, JNK and ERK, and PI3K-I/AKT pathways 
(Fig. 9). Among MAPK cascades, the apoptosis signal-regulated kinase 1 (ASK1) is an 
upstream kinase that regulates MAPK pathways and ca be activated under oxidative 
stress [11,40]. While ASK1 is inhibited by reduced thioredoxin in nonstressed cells, it is 
activated when two cysteine residues of thioredoxin are oxidized, leading to 
dissociation of thioredoxin from ASK1, resulting inthe activation of JNK and p38 
pathways [41]. It was also proposed that MAPK pathwys can also be activated by the 
direct inhibition of MAPK phosphatases by ROS [42]. Similarly, the PI3K pathway is 
subject to reversible redox regulation by ROS. This pathway is negatively regulated by 
the phosphatase and tensin homology (PTEN). It was demonstrated that ROS oxidize 
and inactivate PTEN, causing the activation of the PI3K pathway [14]. When A375 
cells were submitted to PDT in the presence of the antioxidant trolox, p38, JNK, ERK 
and AKT phosphorylation was prevented, indicating that oxidative stress triggered by 
Pc13 PDT is responsible for MAPKs and PI3K-I/AKT pathways activation. 
In the context of PDT, MAPKs and PI3K pathways have be n related to both 
survival and cell death, depending on the tumor cell type, the stimulus duration and the 
photosensitizer employed [22,29,30]. Thus, we studied the role of these intracellular 
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pathways in the phototoxicity of Pc13 in A375 cells. Results obtained demonstrated that 
p38 is involved in the apoptotic cell death triggered by irradiation of Pc13-treated cells 
(Fig. 9). Accordingly, Xue et al. observed p38 activation in the apoptotic response of 
PDT employing the phthalocyanine Pc 4 in CHO cells [43]. In a recent work, the siRNA 
targeting of p38 was used to reveal the mitochondria-mediated apoptosis in ZnPc PDT-
treated colon carcinoma LoVo cells [44]. On the other and, we showed that while 
inhibition of ERK had no considerable effect, the blockage of JNK with a specific 
inhibitor or with over-expression of a dominant negative mutant potentiated the 
phototoxic effect of Pc13, suggesting that JNK participates in cell survival.  
Since autophagy was reported to be involved in both cell death and survival in 
response to oxidative stress [6], the activation of this mechanism after Pc13 PDT was 
herein studied. We found different evidence of autophagy induction, including increase 
of Beclin-1, the conversion of LC3-I to LC3-II and accumulation of LC3 in 
autophagosome vesicles after PDT. While some works p oposed a pro-death role of 
PDT-induced autophagy [22,23,45], other reports suggested that it plays a protective 
role [46,47]. It’s worthy to mention that autophagy triggers cell death in apoptosis 
incompetent cells [48]. In this work, we showed that the inhibition of autophagy 
resulted in an increased Pc13 phototoxicity, indicating that Pc13 PDT-triggered 
autophagy mediates cell survival. 
Autophagy is regulated by different isoforms of PI3K in opposite manner. While 
PI3K-I/AKT signaling pathway blocks the promotion of autophagy via the activation of 
mTOR, a class III PI3K complex, formed with Beclin-1, class III PI3K, and p150, 
recruits LC3 to the membrane of autophagosomes and thereby activates autophagy[49]. 
Since PI3K inhibitors affect both class I and class III PI3K [50], we employed a 
dominant negative of PI3K-I to specifically block AKT cascade. This blockage 
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increased the induction of autophagy and reduced Pc13 phototoxicity, indicating that 
PI3K-I/AKT pathway activated by Pc13 PDT inhibits the induction of a protective 
autophagy. In this sense, Espada et l. reported that the constitutive activation of H-Ras 
or PI3K-I, associated with AKT phosphorylation, is sufficient to protect murine 
keratinocytes from PDT using a Zn phthalocyanine as photosensitizer, indicating that 
this signaling pathway plays a key role in cell survival [51]. Conversely, PI3K 
inhibitors, such as wortmannin and 3-MA, usually employed as autophagy inhibitors, 
increased phototoxic effect of Pc13. Chloroquine, by a different mechanism of 
autophagy inhibition, also increased cell death after PDT. The raise of lysosomal pH 
caused by chloroquine leads to inhibition of both fusion of autophagosome with 
lysosome and lysosomal protein degradation. Taking into account that autophagy 
contributes to cell survival after photodynamic trea ment with Pc13, we further 
evaluated if this mechanism was exacerbated in A375 cells submitted to several cycles 
of Pc13 PDT. Results obtained demonstrated a significa t reduction in sensitivity to 
treatment together with an increase in LC3-II levels in A375 5 PDT and A375 10 PDT cells, 
suggesting that autophagy is a mechanism involved in PDT resistance. Accordingly, 
Martin et al. identified an autophagic response in vemurafenib-resistant melanoma cells 
[52]. Similarly, Rodríguez et al. found that hypoxia activates a HIF-1α/VMP1 
autophagy pathway that confers resistance to PDT in colon cancer cells [46].  
The efficacy of PDT treatment with Pc13 was further demonstrated in 3D 
cultures of A375 cells. It was reported that gene expr ssion profiles of tumor spheroids 
are more similar to in vivo gene expression than those in 2D culture [53]. Furthermore, 
since tumor spheroids resemble the hypoxic condition and cell-cell interactions of in 
vivo tumors, in general they have reduced responsive ess to treatments. We showed 
that the combination of Pc13 PDT with chloroquine was more phototoxic than PDT 
 24
alone. In a recent work, Yu et al. also demonstrated that PDT with an unsubstituted 
ZnPc and 3-MA inhibited tumor growth, indicating tha  autophagy indeed exerts a 
protective role [54].  
Results obtained demonstrated that Pc13-activated JNK has a positive regulation 
in LC3-II formation, since incubation with SP 600125 significantly reduced the 
expression level of LC3-II. In this sense, it was reported that JNK1 mediates the 
phosphorylation of Bcl-2, an inhibitor of Beclin-1, leading to disruption of Bcl-2-
Beclin-1 interaction and autophagy induction [38]. After Pc13 PDT we observed not 
only an increase in Beclin-1, but also a reduction in Bcl-2 levels that may promote 
autophagosome formation. Diminished levels of Bcl-2 are also related to the induction 
of apoptotic cell death after PDT [32]. Thus, the anti- poptotic protein Bcl-2 regulates 
both apoptosis and cell survival by autophagy. In order to confirm the interplay between 
these mechanisms in PDT response, we evaluated the apoptotic response in the presence 
of chloroquine. We proved that autophagy inhibition enhances the apoptotic outcome, 
as evidenced by an augmented cleavage of PARP-1. The crosstalk between apoptosis 
and autophagy was previously demonstrated by different approaches. It was shown that 
ABT737, a BH3 domain mimetic that competitively inhibits the interaction between 
Beclin-1 and Bcl-2, antagonized autophagy inhibition by Bcl-2, stimulating autophagy 
[55]. In the same way, Beclin-1 mutants that cannot bind to Bcl-2 induce more 
autophagy than wild-type Beclin-1 [56]. In addition, caspases, activated during 
apoptosis, can cleave Beclin-1, thereby blocking its pro-autophagic activity [57,58]. On 
the other hand, Beclin-1 can act as an anti-apoptotic protein under different situations, 
including chemotherapy, irradiation, immunotherapy, nutrient deprivation, angiogenesis 
inhibitors and hypoxia [39]. 
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In conclusion, in this work we provide evidence that photodynamic therapy with 
Pc13 is an efficient antitumor modality for melanoma treatment that induces oxidative 
stress, responsible for the activation of MAPKs and PI3K-I/AKT pathways. These 
signaling cascades are involved in the induction of an apoptotic response, but also in 
triggering protective autophagy. While p38 pathway mediates apoptosis, JNK and 
PI3K-I/AKT inversely regulate autophagy (Fig 9). Therefore, the final fate of Pc13 
PDT-treated cells depends on the balance between pro-death and pro-survival 
mechanisms activated in response to the oxidative insult. Thus, the identification of an 
apoptotic-autophagic interplay points out that autophagy blockage is a potential target to 
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Figure 1. Phototoxic effect of Pc13 on human melanoma A375 cells. A) Chemical 
structure of Pc13. B) A375 cells incubated with different concentrations of Pc13 for 24 
h were pretreated or not with 5 mM of the antioxidant trolox, and then maintained in the 
dark or exposed to a light dose of 340 mJ cm-2. Phototoxicity was evaluated 24 h after 
irradiation by hexosaminidase method. Results are expressed as the percentage of cell 
viability relative to control obtained in the absenc  of Pc13 and represent the mean ± 
SEM of three different experiments.  
 
Figure 2. MAPKs and PI3K-I/AKT activation after Pc13 PDT. A) A375 cells 
treated with Pc13 3.60 µM were exposed to a light dose of 340 mJ cm-2 and incubated 
for different time-periods. B) Pc13-treated cells were incubated in the absence or 
presence of 5 mM Trolox for 1 h and then irradiated. Cells were harvested immediately 
after irradiation (time 0 p.i.) for p38 and ERK1/2 or 60 min p.i. for JNK1/2 and AKT 
analyses. Cell lysates (50 µg/lane) were submitted to Western blot assays. 
Representative experiments for p38, ERK1/2, JNK1/2 and AKT are shown. Band 
intensities were quantified using Gel-Pro Analyzer 4.1 software (Media Cybernetics). 
Results are expressed as the relation of phosphorylated to total kinase relative to control 
(irradiated cells without Pc13) and correspond to mean ± SEM of three different 
experiments. ANOVA-Dunnett *p < 0.05, **p < 0.01, significantly different from 
control. 
 
Figure 3. Role of MAPKs p38, ERK, JNK and PI3K-I/AKT in the phototoxicity 
induced by Pc13. A) A375 cells incubated with Pc13 3.60 µM were pretreated or not 
with SB 203580 10 µM, SP 600125 10 µM or PD 98059 20 µM before irradiation with 
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a light dose of 340 mJ cm-2. B) Alternatively, A375 cells transfected with DN p38, DN 
JNK1, DN ERK1/2, DN PI3K-I or the corresponding empty vectors were incubated 
with Pc13 3.60 µM and then irradiated. Cell viability was evaluated after 24 h of 
incubation by hexosaminidase method. C) Detection of cleaved PARP-1 (89 kDa 
fragment) by Western blot assay in lysates (50 µg/lane) of A375 cells submitted to Pc13 
PDT in the absence or presence of SB 203580 10 µM. α-tubulin was used as loading 
control. Densitometric analyses were performed with Gel-Pro Analyzer software. 
Results represent the mean ± SEM, n= 3. ANOVA-Dunnett **p < 0.01, significantly 
different from Pc13 PDT-treated cells without inhibitors (A and C) or transfected with 
the corresponding empty vectors (B); ns, not signifcant.  
 
Figure 4. Induction of autophagy by Pc13 photoactivation. A) A375 cells were 
treated with 3.60 µM Pc13 and irradiated with a light dose 340 mJ cm−2. After 
incubating cells for the indicated times, total proteins were extracted and LC3-I/II was 
detected using Western blot analyses, in which α-tubulin served as a loading control. 
Results obtained by densitometric analyses are expressed as the ratio of LC3-II/tubulin 
relative to control (irradiated cells without Pc13). B  Following transfection with GFP-
LC3 expressing vector, A375 cells were treated with 3.60 µM Pc13, irradiated with a 
light dose of 340 mJ cm−2. At 1 h p.i., cells were examined using a fluorescence 
microscope. The appearance of punctate staining indicates autophagosome-associated 
LC3-II, scale bar 20 µm. C) Western blot of Beclin-1 and Bcl-2 at different times post 
irradiation of Pc13-treated A375 cells. D) A375 cells incubated with 3.60 µM Pc13 
were pretreated with the autophagy inhibitors CQ 20 µM, 3-MA 5 mM or WM 0.5 µM, 
and irradiated with a light dose of 340 mJ cm−2. Phototoxicity was evaluated 24 h after 
irradiation by hexosaminidase method. Results are expressed relative to control 
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obtained in the absence of Pc13 and represent the mean ± SEM, n= 3. ANOVA-Dunnett 
*p < 0.05, **p < 0.01, significantly different from control obtained in the absence of 
Pc13; ##p < 0.01, significantly different from Pc13 PDT-treated cells. 
 
Figure 5. JNK and PI3K-I pathways regulate autophagy induced by Pc13 PDT. 
A375 cells treated with Pc13 3.60 µM were preincubated with SB 203580 10 µM, SP 
600125 10 µM or transiently transfected with a DN PI3K-I vector before irradiation 
with a light dose of 340 mJ cm−2. LC3-II levels were analyzed by Western blot assay of 
cell lysates obtained at 1 h p.i. and α-tubulin was employed as loading control. Results 
from one representative experiment are shown (upper anel). Densitometric analyses 
(lower panel) were performed with Gel-Pro Analyzer software. Results are expressed as 
the ratio of LC3-II/α-tubulin relative to control. ANOVA-Dunnett (n= 3) *p<0.05, **p 
< 0.01, significantly different from Pc13 PDT-treatd A375 cells. 
 
Figure 6. Autophagy is stimulated in resistant cells submitted to repeated cycles of 
Pc13 PDT. A) Schematic representation of Pc13 PDT resistant cells generation. B) 
A375 cells submitted to 5 or 10 cycles of PDT (A3755 PDT and A37510 PDT) or parental 
A375 cells were incubated with different concentrations of Pc13 for 24 h and then 
exposed to a light dose of 340 mJ cm-2. Phototoxicity was evaluated 24 h after 
irradiation by hexosaminidase method. Results are expressed as the percentage of cell 
viability relative to control obtained in the absenc  of Pc13 and represent the mean ± 
SEM of three different experiments. IC50 values, corresponding to the concentrations of 
Pc13 that produce 50% of cell death, are indicated. C) LC3-II levels in A375, A3755 PDT 
and A37510 PDT cells lysates were determined by Western blot assay. α-tubulin was used 
as loading control. Densitometric analyses were performed with Gel-Pro Analyzer 
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software. Results are expressed as the ratio of LC3-II/α-tubulin. ANOVA-Dunnett (n= 
3) *p < 0.05; **p < 0.01, significantly different from A375 cells. D) A375, A3755 PDT 
and A37510 PDT cells were transiently transfected with GFP-LC3 expr ssing vector and 
then cell fluorescence was examined by fluorescence microscopy at 470-490 nm 
excitation and 515 nm emission wavelengths. Punctate s aining indicates 
autophagosome-associated LC3-II. Scale bar 50 µm. 
 
Figure 7. Blockage of autophagy enhances apoptotic response after Pc13 PDT. 
A375 cells treated with Pc13 3.60 µM were incubated for 1 h with CQ 20 µM and then 
irradiated with a light dose of 340 mJ cm−2. Cell lysates obtained at 3 h post irradiation 
were submitted to Western blot assay for PARP-1 fragment (89 kDa) detection. α-
tubulin was used as loading control. Results from one representative experiment are 
shown (upper panel). Densitometric analyses (lower panel) were performed with Gel-
Pro Analyzer software. Results are expressed relativ  to control obtained in the absence 
of Pc13 and represent the mean ± SEM of three different experiments. Student´s t-test 
**p < 0.01. 
 
Figure 8. Pc13-induced phototoxic effect on A375 spheroids. (A) A375 spheroids 
were incubated in the absence or presence of different concentrations of Pc13 (B) with 
or without chloroquine 20 µM and exposed to a light dose of 680 mJ cm−2. Spheroid 
areas were determined at different days post irradiation using Image J software (upper 
panel). Results represent the mean ± S.D., n= 12, ANOVA-Dunnet *p < 0.05, **p < 
0.01 significantly different from control spheroids incubated in the absence of Pc13, #p 
< 0.05, ##p < 0.01 significantly different from PDT treated-spheroids (Pc13 2.5 µM). 
Representative images of A375 spheroids are shown (lo er panels). Scale bar 500 µm. 
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Figure 9. Signaling pathways triggered by Pc13 PDT in A375 melanoma cells. The 
irradiation of Pc13-loaded cells triggers the activation of ROS-mediated MAPKs p38, 
ERK, JNK and PI3K-I/AKT pathways. These pathways have different roles in the 
induction of apoptotic cell death and protective autophagy. While p38 mediates the 
apoptotic response, JNK promotes and PI3K-I/AKT pathw y negatively regulates cell 
survival by autophagy. The balance between these mechanisms determines the final fate 
of the cell and modulates PDT efficacy. 
 
Supplementary figure 1. Transfection of A375 cells with dominant negative 
mutants inhibits MAPKs and PI3K-I pathways. A375 cells transfected or not with 
DN p38, DN JNK1, DN ERK1/2 or DN PI3K-I were incubated in the absence or 
presence of Pc13 3.60 µM for 24 h. Then, cells were irradiated with a light dose of 340 
mJ cm-2 and harvested immediately after irradiation (time 0 p.i.) or 60 min p.i. to 
evaluate p38 and ERK or JNK and PI3K-I pathway inhibition, respectively. Cell lysates 
(50 µg/lane) were submitted to Western blot assays. Repres ntative blots of downstream 
targets of each kinases are shown: p-p38 (p38), p-p90 (ERK), p-cJun (JNK) and AKT 
(PI3K-I).  
 
Supplementary figure 2. A375 spheroids viability decreased after Pc13 PDT. A375 
spheroids incubated or not with different concentrations of Pc13 were exposed to a light 
dose of 680 mJ cm−2. 10 days after irradiation, spheroids were disaggre ated with 
trypsin and cell viability was determined by MTT reduction assay. Results are 
expressed as the percentage of cell viability relative to control obtained in the absence 
of Pc13 and represent the mean ± SEM of three different experiments.  
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- Pc13 is a potent photosensitizer in 2D and 3D melanoma cultures 
- Oxidative stress induced by Pc13 PDT activates p38, JNK, ERK and PI3K-I/AKT 
pathways 
- Pc13 PDT triggers apoptosis through p38 pathway  
- JNK and PI3K-I/AKT pathways regulate Pc13 PDT-induced autophagy 
- Inhibition of autophagy potentiates the Pc13 apoptotic response  
 
